JPH0892214A - Production of new hydroquinone and benzoquinone derivative - Google Patents
Production of new hydroquinone and benzoquinone derivativeInfo
- Publication number
- JPH0892214A JPH0892214A JP17799794A JP17799794A JPH0892214A JP H0892214 A JPH0892214 A JP H0892214A JP 17799794 A JP17799794 A JP 17799794A JP 17799794 A JP17799794 A JP 17799794A JP H0892214 A JPH0892214 A JP H0892214A
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen atom
- group
- formula
- lower alkyl
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 16
- 150000004057 1,4-benzoquinones Chemical class 0.000 title claims abstract description 8
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 title abstract description 13
- 150000001875 compounds Chemical class 0.000 claims abstract description 35
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 28
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 28
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 claims abstract description 19
- 150000003839 salts Chemical class 0.000 claims abstract description 14
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 12
- 239000002253 acid Substances 0.000 claims abstract description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 43
- 239000000126 substance Substances 0.000 claims description 22
- -1 3,5-Dimethyl-2- (hydroxy-3-pyridylmethyl) benzene Chemical compound 0.000 claims description 13
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 12
- 125000005843 halogen group Chemical group 0.000 claims description 10
- QJZUKDFHGGYHMC-UHFFFAOYSA-N pyridine-3-carbaldehyde Chemical compound O=CC1=CC=CN=C1 QJZUKDFHGGYHMC-UHFFFAOYSA-N 0.000 claims description 9
- 230000001590 oxidative effect Effects 0.000 claims description 5
- 150000001299 aldehydes Chemical class 0.000 claims 2
- NQPGVPMWUYRYPX-UHFFFAOYSA-N 2-[hydroxy(pyridin-3-yl)methyl]-3,5-dimethylcyclohexa-2,5-diene-1,4-dione Chemical compound O=C1C(C)=CC(=O)C(C(O)C=2C=NC=CC=2)=C1C NQPGVPMWUYRYPX-UHFFFAOYSA-N 0.000 claims 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 abstract description 10
- 238000007254 oxidation reaction Methods 0.000 abstract description 9
- 229960004337 hydroquinone Drugs 0.000 abstract description 8
- 230000003647 oxidation Effects 0.000 abstract description 8
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 abstract description 4
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 150000002617 leukotrienes Chemical class 0.000 abstract description 3
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- KOUMLUHJJOCBRP-UHFFFAOYSA-N 2-[hydroxy(pyridin-3-yl)methyl]-3,5-dimethylbenzene-1,4-diol Chemical compound CC1=C(O)C(C)=CC(O)=C1C(O)C1=CC=CN=C1 KOUMLUHJJOCBRP-UHFFFAOYSA-N 0.000 abstract 1
- QREOEYCWXPWXRA-UHFFFAOYSA-N 2-[hydroxy(pyridin-3-yl)methyl]-3,5-dimethylcyclohexa-2,5-diene-1,4-dione;hydrochloride Chemical compound Cl.O=C1C(C)=CC(=O)C(C(O)C=2C=NC=CC=2)=C1C QREOEYCWXPWXRA-UHFFFAOYSA-N 0.000 abstract 1
- 238000006482 condensation reaction Methods 0.000 abstract 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 135
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 27
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 24
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 23
- 238000001816 cooling Methods 0.000 description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 20
- 239000000203 mixture Substances 0.000 description 19
- 239000000243 solution Substances 0.000 description 19
- 229910052739 hydrogen Inorganic materials 0.000 description 16
- 238000005160 1H NMR spectroscopy Methods 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 238000001914 filtration Methods 0.000 description 15
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 12
- 235000019341 magnesium sulphate Nutrition 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 235000017557 sodium bicarbonate Nutrition 0.000 description 11
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 11
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 238000002844 melting Methods 0.000 description 10
- 230000008018 melting Effects 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 239000013078 crystal Substances 0.000 description 9
- 238000000354 decomposition reaction Methods 0.000 description 9
- 238000000921 elemental analysis Methods 0.000 description 9
- 239000002244 precipitate Substances 0.000 description 8
- 229940005561 1,4-benzoquinone Drugs 0.000 description 7
- MVEAAGBEUOMFRX-UHFFFAOYSA-N ethyl acetate;hydrochloride Chemical compound Cl.CCOC(C)=O MVEAAGBEUOMFRX-UHFFFAOYSA-N 0.000 description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 239000010410 layer Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 description 5
- 238000010898 silica gel chromatography Methods 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- MVQVNTPHUGQQHK-UHFFFAOYSA-N 3-pyridinemethanol Chemical group OCC1=CC=CN=C1 MVQVNTPHUGQQHK-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 4
- RTBFZNKEWQAVEO-UHFFFAOYSA-N benzene-1,4-diol;hydrochloride Chemical compound Cl.OC1=CC=C(O)C=C1 RTBFZNKEWQAVEO-UHFFFAOYSA-N 0.000 description 4
- XMPZTFVPEKAKFH-UHFFFAOYSA-P ceric ammonium nitrate Chemical compound [NH4+].[NH4+].[Ce+4].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O XMPZTFVPEKAKFH-UHFFFAOYSA-P 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000001241 acetals Chemical class 0.000 description 3
- 229910017604 nitric acid Inorganic materials 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 3
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- OHBQPCCCRFSCAX-UHFFFAOYSA-N 1,4-Dimethoxybenzene Chemical class COC1=CC=C(OC)C=C1 OHBQPCCCRFSCAX-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- SWQATTIVGVDYMO-UHFFFAOYSA-N 2-(pyridin-2-ylmethyl)cyclohexa-2,5-diene-1,4-dione Chemical class O=C1C=CC(=O)C(CC=2N=CC=CC=2)=C1 SWQATTIVGVDYMO-UHFFFAOYSA-N 0.000 description 1
- BALCQUMLTNEBGC-UHFFFAOYSA-N 2-[hydroxy(pyridin-3-yl)methyl]-3,5,6-trimethylbenzene-1,4-diol Chemical compound CC1=C(O)C(C)=C(C)C(O)=C1C(O)C1=CC=CN=C1 BALCQUMLTNEBGC-UHFFFAOYSA-N 0.000 description 1
- AGOYXVGJPFLKDQ-UHFFFAOYSA-N 2-[hydroxy(pyridin-3-yl)methyl]-5-methylbenzene-1,4-diol Chemical compound C1=C(O)C(C)=CC(O)=C1C(O)C1=CC=CN=C1 AGOYXVGJPFLKDQ-UHFFFAOYSA-N 0.000 description 1
- XUMMODAFYHVFHL-UHFFFAOYSA-N 2-[hydroxy(pyridin-3-yl)methyl]benzene-1,4-diol Chemical compound C=1C(O)=CC=C(O)C=1C(O)C1=CC=CN=C1 XUMMODAFYHVFHL-UHFFFAOYSA-N 0.000 description 1
- CSDSSGBPEUDDEE-UHFFFAOYSA-N 2-formylpyridine Chemical compound O=CC1=CC=CC=N1 CSDSSGBPEUDDEE-UHFFFAOYSA-N 0.000 description 1
- AYWUOITYNKUIGN-UHFFFAOYSA-N 3,5-dimethyl-2-[propan-2-yloxy(pyridin-3-yl)methyl]benzene-1,4-diol Chemical compound OC=1C=C(C)C(O)=C(C)C=1C(OC(C)C)C1=CC=CN=C1 AYWUOITYNKUIGN-UHFFFAOYSA-N 0.000 description 1
- XRZSECIWTDDOMI-UHFFFAOYSA-N 3-[di(propan-2-yloxy)methyl]pyridine Chemical compound CC(C)OC(OC(C)C)C1=CC=CN=C1 XRZSECIWTDDOMI-UHFFFAOYSA-N 0.000 description 1
- ZZODGJCLGMORLC-UHFFFAOYSA-N 4-[hydroxy(pyridin-3-yl)methyl]-5,7-dimethyl-2-(methylamino)-1,3-benzothiazol-6-ol Chemical compound CC1=C(O)C(C)=C2SC(NC)=NC2=C1C(O)C1=CC=CN=C1 ZZODGJCLGMORLC-UHFFFAOYSA-N 0.000 description 1
- LHHCKCQUJYHUGF-UHFFFAOYSA-N 6-amino-4-(1,3-benzothiazol-2-ylmethyl)-1H-pyridin-2-one Chemical class NC1=NC(=CC(=C1)CC=1SC2=C(N=1)C=CC=C2)O LHHCKCQUJYHUGF-UHFFFAOYSA-N 0.000 description 1
- XTRLIKXVRGWTKW-UHFFFAOYSA-N 6-chloropyridine-2-carbaldehyde Chemical compound ClC1=CC=CC(C=O)=N1 XTRLIKXVRGWTKW-UHFFFAOYSA-N 0.000 description 1
- AHISYUZBWDSPQL-UHFFFAOYSA-N 6-methylpyridine-2-carbaldehyde Chemical compound CC1=CC=CC(C=O)=N1 AHISYUZBWDSPQL-UHFFFAOYSA-N 0.000 description 1
- 102000001381 Arachidonate 5-Lipoxygenase Human genes 0.000 description 1
- 108010093579 Arachidonate 5-lipoxygenase Proteins 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- IONAQTGMWFXHIX-UHFFFAOYSA-N E3040 Chemical compound CC1=C(O)C(C)=C2SC(NC)=NC2=C1CC1=CC=CN=C1 IONAQTGMWFXHIX-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- KQJQICVXLJTWQD-UHFFFAOYSA-N N-Methylthiourea Chemical compound CNC(N)=S KQJQICVXLJTWQD-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 125000004849 alkoxymethyl group Chemical group 0.000 description 1
- 125000005233 alkylalcohol group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- 229960003280 cupric chloride Drugs 0.000 description 1
- 150000005575 dimethoxybenzenes Chemical class 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- GRWZHXKQBITJKP-UHFFFAOYSA-L dithionite(2-) Chemical compound [O-]S(=O)S([O-])=O GRWZHXKQBITJKP-UHFFFAOYSA-L 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 229940032296 ferric chloride Drugs 0.000 description 1
- 229940044631 ferric chloride hexahydrate Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- NQXWGWZJXJUMQB-UHFFFAOYSA-K iron trichloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].Cl[Fe+]Cl NQXWGWZJXJUMQB-UHFFFAOYSA-K 0.000 description 1
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 1
- 229910000360 iron(III) sulfate Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 230000001035 methylating effect Effects 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 1
- 125000006606 n-butoxy group Chemical group 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003506 n-propoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- IHSLHAZEJBXKMN-UHFFFAOYSA-L potassium nitrosodisulfonate Chemical compound [K+].[K+].[O-]S(=O)(=O)N([O])S([O-])(=O)=O IHSLHAZEJBXKMN-UHFFFAOYSA-L 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- BGUWFUQJCDRPTL-UHFFFAOYSA-N pyridine-4-carbaldehyde Chemical compound O=CC1=CC=NC=C1 BGUWFUQJCDRPTL-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- CNHDIAIOKMXOLK-UHFFFAOYSA-N toluquinol Chemical compound CC1=CC(O)=CC=C1O CNHDIAIOKMXOLK-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は特開平5−178855
号公報に開示されているロイコトリエンおよびトロンボ
キサン産成抑制作用が有効な疾患の予防と治療に有用な
ベンゾチアゾール誘導体の重要合成中間体の製造法に関
する。FIELD OF THE INVENTION The present invention is disclosed in JP-A-5-178855.
The present invention relates to a method for producing an important synthetic intermediate of a benzothiazole derivative which is useful for the prevention and treatment of diseases for which leukotriene and thromboxane production inhibitory effects are disclosed.
【0002】[0002]
【従来の技術】一般式(IV)で表されるピリジニルメ
チル−1,4−ベンゾキノン誘導体に類似の化合物(V
I)の製造法は特願平4−64545号公報に示されて
いる。それは、下記反応式(R5 、R6 は同一または異
なって水素原子、低級アルキル基または低級アルコキシ
基を、R7 は低級アルキル基を意味する)に示すごと
く、出発原料としてジメトキシベンゼン誘導体を用いピ
リジルメタノール基を導入し、硝酸第二セリウムアンモ
ニウムにより酸化する方法である。2. Description of the Related Art A compound similar to the pyridinylmethyl-1,4-benzoquinone derivative represented by the general formula (IV) (V
The manufacturing method of I) is shown in Japanese Patent Application No. 4-64545. As shown in the following reaction formula (R 5 and R 6 are the same or different and each represents a hydrogen atom, a lower alkyl group or a lower alkoxy group, and R 7 is a lower alkyl group), a dimethoxybenzene derivative is used as a starting material. In this method, a pyridylmethanol group is introduced and oxidized with ceric ammonium nitrate.
【0003】[0003]
【化13】 [Chemical 13]
【0004】[0004]
【本発明が解決しようとする課題】従来の製造法におい
て出発原料として用いられている2,5−ジメトキシベ
ンゼン誘導体は、次の反応のピリジルメタノール基の導
入に際し使用される試薬(n−BuLi)の特性から水
酸基を保護することが必要で、その目的で下記反応式に
示すごとくヒドロキノン誘導体(R5 、R6 は前記を意
味する)をメチル化して得たものである。ピリジルメタ
ノール基導入後、目的とする1,4−ベンゾキノン製造
のために行う酸化工程ではこのメチル基(保護基)が酸
化され脱メチル化が起こることを考えると、このメチル
化は全く無駄な工程であり、工業的に不利である。また
酸化反応においてはメトキシ体(水酸基の保護体)の方
がヒドロキシ体より反応に抵抗することから、酸化の条
件に制限が加わることになり、この点でもメトキシ体
(水酸基の保護体)は不利である。そのため、ヒドロキ
ノン誘導体の水酸基を保護することなくピリジルメタノ
ール基を導入する工業的製法とそれに続く安価な酸化の
条件の確立が望まれていた。The 2,5-dimethoxybenzene derivative used as a starting material in the conventional production method is a reagent (n-BuLi) used for introducing a pyridylmethanol group in the next reaction. It is necessary to protect the hydroxyl group from the above characteristic, and for that purpose, it is obtained by methylating a hydroquinone derivative (R 5 and R 6 have the above meanings) as shown in the following reaction formula. Considering that the methyl group (protecting group) is oxidized and demethylated in the oxidation step for producing the desired 1,4-benzoquinone after introducing the pyridylmethanol group, this methylation is a completely useless step. And is industrially disadvantageous. Further, in the oxidation reaction, the methoxy form (protective group of hydroxyl group) resists the reaction more than the hydroxy form, which imposes restrictions on the conditions of oxidation. In this respect also, the methoxy form (protective group of hydroxyl group) is disadvantageous. Is. Therefore, it has been desired to establish an industrial production method of introducing a pyridylmethanol group without protecting the hydroxyl group of the hydroquinone derivative and a subsequent inexpensive oxidation condition.
【0005】[0005]
【化14】 Embedded image
【課題を解決するための手段】本発明者等は一般式
(I)で示されるヒドロキノン誘導体の水酸基を保護す
ることなくピリジルメチル基を導入する製造法につき鋭
意検討を重ねた。その結果、一般式(I)で示されるヒ
ドロキノン誘導体を、その水酸基を保護することなく、
一般式(II)で示されるピリジルアルデヒドあるいは
一般式(II’)で示されるアルキルアセタール誘導体
と酸の存在下に処理することにより一般式(III)で
示されるピリジルメチルヒドロキノン誘導体の製造方法
を見いだした。そして安価な酸化の条件でのピリジルメ
チル−1,4−ベンゾキノン誘導体(IV)の製造法を
確立し、本発明を完成した。Means for Solving the Problems The inventors of the present invention have conducted extensive studies on a production method of introducing a pyridylmethyl group without protecting the hydroxyl group of the hydroquinone derivative represented by the general formula (I). As a result, the hydroquinone derivative represented by the general formula (I) was treated without protecting its hydroxyl group,
A process for producing a pyridylmethylhydroquinone derivative represented by the general formula (III) by treating with a pyridyl aldehyde represented by the general formula (II) or an alkyl acetal derivative represented by the general formula (II ') in the presence of an acid was found. It was Then, a method for producing the pyridylmethyl-1,4-benzoquinone derivative (IV) under the conditions of inexpensive oxidation was established, and the present invention was completed.
【0006】以下、本発明について詳しく説明する。The present invention will be described in detail below.
【0007】(1)ピリジルメチル基の導入工程(1) Step of introducing a pyridylmethyl group
【化15】 式中、R1 は水素原子、メチル基またはメトキシ基を、
R2 およびR3 は同一または異なって水素原子またはメ
チル基を、R4 は水素原子または低級アルキル基を、
R’は低級アルキル基を、Xは水素原子、低級アルキル
基、低級アルコキシ基またはハロゲン原子を意味する。
本工程はヒドロキノン誘導体(I)とピリジルアルデヒ
ド誘導体(II)あるいはそのアセタール誘導体(I
I’)を酸の存在下に縮合しピリジルメチル誘導体(I
II)を得る工程である。酸として、例えば塩酸、硫
酸、りん酸、トリフロロ酢酸、メタンスルホン酸などを
挙げることができる。 反応溶媒として、水、メタノー
ル、エタノール、プロパノール、イソプロパノール、塩
化メチレン、1,2−ジクロロエタン、ベンゼン、トル
エンなどを挙げることができる。反応温度は−10℃か
ら100℃、好ましくは10℃から30℃の範囲であ
る。また、ピリジルアルデヒド誘導体(II)と低級ア
ルキルアルコールから得られるアセタール誘導体(I
I’)との縮合においては、生成するアセタールを単離
することなく反応溶液中に直接ヒドロキノン誘導体
(I)を加えることによってもピリジルアルコキシメチ
ル−1,4ーヒドロキノン誘導体(III)を得ること
が可能である。なお、原料化合物(I)のヒドロキノン
誘導体は、ジャーナル・オブ・アメリカン・ケミカル・
ソサイエティ(J.Am.Chem.Soc.)194
4年66巻1330頁に記載の方法、あるいはブレティ
ン・オブ・ザ・ケミカル・ソサイエティ・オブ・ジャパ
ン(Bull.Chem.Soc.Jpn.)1992
年65巻1522頁に記載の方法によって得られる1,
4−ベンゾキノン誘導体を緩和な還元剤であるナトリウ
ムハイドロサルファイト、酸性亜硫酸ナトリウム、水素
化ホウ素ナトリウムを用いてそれ自体常法公知の方法で
または酸化白金、パラジウム−炭素の存在下に還元する
ことにより容易に得られる。[Chemical 15] In the formula, R 1 represents a hydrogen atom, a methyl group or a methoxy group,
R 2 and R 3 are the same or different and each is a hydrogen atom or a methyl group, R 4 is a hydrogen atom or a lower alkyl group,
R'represents a lower alkyl group and X represents a hydrogen atom, a lower alkyl group, a lower alkoxy group or a halogen atom.
This step comprises hydroquinone derivative (I) and pyridylaldehyde derivative (II) or its acetal derivative (I
I ′) is condensed in the presence of an acid to produce a pyridylmethyl derivative (I
This is the step of obtaining II). Examples of the acid include hydrochloric acid, sulfuric acid, phosphoric acid, trifluoroacetic acid, methanesulfonic acid and the like. Examples of the reaction solvent include water, methanol, ethanol, propanol, isopropanol, methylene chloride, 1,2-dichloroethane, benzene, toluene and the like. The reaction temperature is in the range of -10 ° C to 100 ° C, preferably 10 ° C to 30 ° C. Further, an acetal derivative (I obtained from a pyridyl aldehyde derivative (II) and a lower alkyl alcohol (I
In the condensation with I ′), the pyridylalkoxymethyl-1,4-hydroquinone derivative (III) can be obtained by directly adding the hydroquinone derivative (I) to the reaction solution without isolating the acetal to be produced. Is. The hydroquinone derivative of the raw material compound (I) is a product of Journal of American Chemicals.
Society (J. Am. Chem. Soc.) 194
4 years, 66, 1330, or Bulletin of the Chemical Society of Japan (Bull. Chem. Soc. Jpn.) 1992.
1, 65 obtained by the method described on page 1,522
By reducing the 4-benzoquinone derivative with sodium mild hydrosulfite, sodium acid sulfite, sodium borohydride, which are mild reducing agents, by a method known per se or in the presence of platinum oxide, palladium-carbon. Easily obtained.
【0008】(2)ヒドロキノンからベンゾキノンへの
酸化の工程(2) Step of oxidation of hydroquinone to benzoquinone
【0009】[0009]
【化16】 式中、R1 は水素原子、メチル基またはメトキシ基を、
R2 およびR3 は同一または異なって水素原子またはメ
チル基を、R4 は水素原子または低級アルキル基を、X
は水素原子、低級アルキル基、低級アルコキシ基または
ハロゲン原子を意味する。本工程はヒドロキノン誘導体
(III)から1,4−ベンゾキノン誘導体(IV)へ
の酸化の工程である。酸化剤としては緩和な酸化剤から
使用が可能で、例えば、空気、酸素、フレミー塩(Fr
emy’salt)、塩化第二鉄、硫酸第二鉄、過酸化
水素、過酸、酸化銀、硝酸第二セリウムアンモニウム、
硝酸などを挙げることができる。これらの反応は通常溶
媒の存在下に行われ該溶媒としては、例えばメタノー
ル、アセトニトリル、テトラヒドロフラン、ジオキサ
ン、酢酸エチル、1,2−ジメトキシエタン、酢酸およ
びこれらの有機溶媒と水からなる含水溶媒または水が挙
げられる。反応温度は−10℃から100℃、好ましく
は−10℃から30℃の範囲で、反応の時間は1分から
3日である。[Chemical 16] In the formula, R 1 represents a hydrogen atom, a methyl group or a methoxy group,
R 2 and R 3 are the same or different and each is a hydrogen atom or a methyl group; R 4 is a hydrogen atom or a lower alkyl group;
Means a hydrogen atom, a lower alkyl group, a lower alkoxy group or a halogen atom. This step is a step of oxidizing the hydroquinone derivative (III) to the 1,4-benzoquinone derivative (IV). As the oxidant, any mild oxidant can be used, and examples thereof include air, oxygen, and Fremy's salt (Fr
emy'salt), ferric chloride, ferric sulfate, hydrogen peroxide, peracid, silver oxide, ceric ammonium nitrate,
Nitric acid etc. can be mentioned. These reactions are usually carried out in the presence of a solvent, and examples of the solvent include methanol, acetonitrile, tetrahydrofuran, dioxane, ethyl acetate, 1,2-dimethoxyethane, acetic acid and a water-containing solvent or water containing these organic solvents and water. Is mentioned. The reaction temperature is -10 ° C to 100 ° C, preferably -10 ° C to 30 ° C, and the reaction time is 1 minute to 3 days.
【0010】上記一般式(III)および(IV)にお
いてR4 およびXの定義中の低級アルキル基とは、炭素
数1〜4の直鎖もしくは分枝状のアルキル基、例えばメ
チル基、エチル基、n−プロピル基、イソプロピル基、
n−ブチル基、イソブチル基、s−ブチル基などを意味
する。これらのうち好ましい基としてはメチル基、エチ
ル基、n−プロピル基、イソプロピル基などを挙げるこ
とができる。またXの定義中の低級アルコキシ基とはメ
トキシ基、エトキシ基、n−プロポキシ基、イソプロポ
キシ基、n−ブトキシ基などを、ハロゲン原子とはフッ
素原子、塩素原子、臭素原子を挙げることができる。In the above general formulas (III) and (IV), the lower alkyl group in the definition of R 4 and X is a linear or branched alkyl group having 1 to 4 carbon atoms, such as a methyl group or an ethyl group. , N-propyl group, isopropyl group,
It means an n-butyl group, an isobutyl group, an s-butyl group and the like. Of these, preferred groups include a methyl group, an ethyl group, an n-propyl group, an isopropyl group and the like. The lower alkoxy group in the definition of X includes a methoxy group, an ethoxy group, an n-propoxy group, an isopropoxy group, an n-butoxy group and the like, and the halogen atom includes a fluorine atom, a chlorine atom and a bromine atom. .
【0011】以上のように本発明は工業的製法上非常に
有利な方法である。即ち、ヒドロキノン誘導体の水酸基
をわざわざメチル基のような保護基で保護することな
く、ピリジルメチル基を直接導入することが可能であ
る。そして、それによりベンゾキノンへの酸化は緩和な
条件から可能となり、安価な酸化条件が選べる。As described above, the present invention is a very advantageous method in industrial production. That is, it is possible to directly introduce the pyridylmethyl group without protecting the hydroxyl group of the hydroquinone derivative with a protective group such as a methyl group. As a result, oxidation to benzoquinone becomes possible under mild conditions, and inexpensive oxidation conditions can be selected.
【0012】本発明で製造されたキノン化合物(IV)
は特開平5−178855号あるいは特願平5−202
552号に開示された反応を用いて、チオウレアH2 N
−C(=S)−NR15R16(R15およびR16は同一また
は相異なる水素原子、低級アルキル基またはピリジルア
ルキル基を意味する)と反応させ、2−アミノ−6−ヒ
ドロキシ−4−(ピリジル−ヒドロキシあるいはアルコ
キシ−メチル)ベンゾチアゾール誘導体(VII)を得
る。The quinone compound (IV) produced by the present invention
JP-A-5-178855 or Japanese Patent Application No. 5-202
Thiourea H 2 N using the reaction disclosed in No. 552
-C (= S) -NR 15 R 16 (R 15 and R 16 are identical or different hydrogen atom, means a lower alkyl group or a pyridyl group) was reacted 2-amino-6-hydroxy-4- A (pyridyl-hydroxy or alkoxy-methyl) benzothiazole derivative (VII) is obtained.
【0013】[0013]
【化17】 [Chemical 17]
【0014】これを酢酸中で加熱処理すると、R4 Oが
還元的に脱離し、2−アミノ−6−ヒドロキシ−4−ピ
リジルメチルベンゾチアゾール誘導体が得られる。この
化合物は、特会平5−178855号、特に実施例10
に開示されているように、5−リポキシゲナーゼ阻害作
用およびトロンボキサン産成抑制作用によるロイコトリ
エンおよびトロンボキサン産成抑制作用が有効な疾患、
特に潰瘍性大腸炎の予防と治療に有効である。When this is heated in acetic acid, R 4 O is reductively eliminated to give a 2-amino-6-hydroxy-4-pyridylmethylbenzothiazole derivative. This compound can be obtained by the method described in JP-A-5-178855, especially in Example 10.
As disclosed in, a disease in which the leukotriene and thromboxane production inhibitory action by the 5-lipoxygenase inhibitory action and the thromboxane production inhibitory action is effective,
It is especially effective in the prevention and treatment of ulcerative colitis.
【0015】以下に本発明の実施例を挙げるが、本発明
がこれらの実施例に限定されるものでないことは言うま
でもない。Examples of the present invention will be given below, but it goes without saying that the present invention is not limited to these examples.
【0016】実施例13,5−ジメチル−2−(ヒドロキシ−3−ピリジルメ
チル)ベンゼン−1,4−ジオール Example 1 3,5-Dimethyl-2- (hydroxy-3-pyridylme
Chill) benzene-1,4-diol
【0017】[0017]
【化18】 [Chemical 18]
【0018】氷冷下、6N塩酸250mlに3−ピリジ
ンカルボキシアルデヒド14ml(0.15mol)を
滴下し、次に2,6−ジメチル−p−ヒドロキノン25
g(0.18mol)を加え、室温で17時間攪拌し
た。この反応混合物に水300ml、酢酸エチル25m
lを加え、次いで氷冷下に、激しく攪拌しながら炭酸水
素ナトリウム111g(1.32mol)を少しずつ加
えた後、10分間攪拌し、析出する結晶を濾取した。こ
れを水、酢酸エチル、イソプロピルエーテルで順次浄
後、乾燥して表記化合物33.0g(収率91%)を得
た。 融点:181−183℃ 元素分析値C14H15NO3 として 計算値 C,68.56;H,6.16;N,5.71 実測値 C,68.32;H,6.19;N,5.451 H−NMR(400MHz,DMSO−d6 )δ;
1.91(3H,s),2.07(3H,s),6.2
8(1H,s),6.45(1H,s),7.27(1
H,dd,J=4.0,8.0Hz),7.57(1
H,d,J=8.0Hz),8.36(1H,d,J=
4.0Hz),8.42(1H,s). MS(FAB):m/z246(M+H)+ .Under ice cooling, 14 ml (0.15 mol) of 3-pyridinecarboxaldehyde was added dropwise to 250 ml of 6N hydrochloric acid, and then 2,6-dimethyl-p-hydroquinone 25 was added.
g (0.18 mol) was added, and the mixture was stirred at room temperature for 17 hours. 300 ml of water and 25 m of ethyl acetate were added to the reaction mixture.
Then, 111 g (1.32 mol) of sodium hydrogencarbonate was added little by little with vigorous stirring under ice cooling, and the mixture was stirred for 10 minutes, and the precipitated crystals were collected by filtration. This was sequentially purified with water, ethyl acetate and isopropyl ether and then dried to obtain 33.0 g (yield 91%) of the title compound. Melting point: 181-183 ° C. Elemental analysis value Calculated value as C 14 H 15 NO 3 C, 68.56; H, 6.16; N, 5.71 Measured value C, 68.32; H, 6.19; N , 5.45 1 H-NMR (400 MHz, DMSO-d 6 ) δ;
1.91 (3H, s), 2.07 (3H, s), 6.2
8 (1H, s), 6.45 (1H, s), 7.27 (1
H, dd, J = 4.0, 8.0 Hz), 7.57 (1
H, d, J = 8.0 Hz), 8.36 (1H, d, J =
4.0 Hz), 8.42 (1H, s). MS (FAB): m / z 246 (M + H) + .
【0019】実施例23,5−ジメチル−2−(メトキシ−3−ピリジルメチ
ル)ベンゼン−1,4−ジオール塩酸塩 Example 2 3,5-Dimethyl-2- (methoxy-3-pyridylmethyi)
Le) Benzene-1,4-diol hydrochloride
【0020】[0020]
【化19】 [Chemical 19]
【0021】3−ピリジンカルボキシアルデヒド1.0
ml(10.6mmol)のメタノール(15ml)溶
液に、氷冷下塩酸ガスを50分間導入した。次に2,6
−ジメチル−p−ヒドロキノン1.6g(11.6mm
ol)を加え、氷冷下1時間攪拌した後、メタノールを
減圧留去し、残渣に水、酢酸エチルを加え、炭酸水素ナ
トリウムで中和し、有機層を分取し、硫酸マグネシウム
で乾燥した。溶媒を減圧下に留去後、残渣をシリカゲル
カラムクロマトグラフィー(酢酸エチル:n−ヘキサン
=1:1)にて精製し、表記化合物のフリー体1.8g
を得た。これを水、酢酸エチル36mlに溶かし、氷冷
下に4N塩化水素−酢酸エチル2.1mlを滴下し、1
0分間攪拌後、析出する結晶を濾取し、酢酸エチル、イ
ソプロピルエーテルで順次洗浄後、乾燥して表記化合物
1.8g(収率58%)を得た。 融点:177−178℃ 元素分析値 C15H17NO3 ・HClとして 計算値 C,60.91;H,6.13;N,4.74 実測値 C,60.54;H,6.13;N,4.731 H−NMR(400MHz,DMSO−d6 )δ;
1.88(3H,s),2.09(3H,s),3.2
9(3H、s),6.14(1H,s),6.56(1
H,s),7.90(1H,dd,J=5.6,8.0
Hz),8.14(1H,d,J=8.0Hz),8.
59(1H,s),8.75(1H,d,J=5.6H
z),9.10(1H,br s). MS(FAB):m/z260(M+H)+ .3-pyridinecarboxaldehyde 1.0
Hydrochloric acid gas was introduced into a methanol (15 ml) solution of ml (10.6 mmol) under ice cooling for 50 minutes. Next 2, 6
-Dimethyl-p-hydroquinone 1.6 g (11.6 mm
ol) was added and the mixture was stirred under ice-cooling for 1 hour, then methanol was distilled off under reduced pressure, water and ethyl acetate were added to the residue, and the mixture was neutralized with sodium hydrogen carbonate. The organic layer was separated and dried over magnesium sulfate. . After the solvent was distilled off under reduced pressure, the residue was purified by silica gel column chromatography (ethyl acetate: n-hexane = 1: 1) to give 1.8 g of the title compound in free form.
Got This was dissolved in 36 ml of water and ethyl acetate, 2.1 ml of 4N hydrogen chloride-ethyl acetate was added dropwise under ice cooling, and 1
After stirring for 0 minutes, the precipitated crystals were collected by filtration, washed successively with ethyl acetate and isopropyl ether, and dried to give the title compound (1.8 g, yield 58%). Mp: 177-178 Calculated C as ℃ Elemental analysis C 15 H 17 NO 3 · HCl , 60.91; H, 6.13; N, 4.74 Found C, 60.54; H, 6.13 ; N, 4.73 1 H-NMR (400MHz, DMSO-d 6) δ;
1.88 (3H, s), 2.09 (3H, s), 3.2
9 (3H, s), 6.14 (1H, s), 6.56 (1
H, s), 7.90 (1H, dd, J = 5.6, 8.0)
Hz), 8.14 (1H, d, J = 8.0 Hz), 8.
59 (1H, s), 8.75 (1H, d, J = 5.6H
z), 9.10 (1H, br s). MS (FAB): m / z 260 (M + H) + .
【0022】実施例33,5−ジメチル−2−(ヒドロキシ−4−ピリジルメ
チル)ベンゼン−1,4−ジオール Example 3 3,5-Dimethyl-2- (hydroxy-4-pyridylme)
Chill) benzene-1,4-diol
【0023】[0023]
【化20】 Embedded image
【0024】氷冷下、6N塩酸8mlに4−ピリジンカ
ルボキシアルデヒド1.0ml(10.5mmol)を
滴下し、次に2,6−ジメチル−p−ヒドロキノン1.
59g(11.5mmol)を加え、室温で17時間攪
拌した。この反応混合物に水30ml、酢酸エチル20
mlを加え、次いで氷冷下に、激しく攪拌しながら炭酸
水素ナトリウムを少しずつ加えてpH6.5に調整し、
酢酸エチル層を分液し、硫酸マグネシウムで乾燥後、溶
媒を減圧留去した。残渣に酢酸エチル50mlを加え、
氷冷下1時間攪拌して析出する結晶を濾取し、酢酸エチ
ル、イソプロピルエーテルで順次洗浄後、乾燥して表記
化合物2.02g(収率79%)を得た。 融点:158−159℃ 元素分析値C14H15NO3 として 計算値 C,68.56;H,6.16;N,5.71 実測値 C,68.52;H,6.17;N,5.661 H−NMR(400MHz,DMSO−d6 )δ;
1.88(3H,s),2.06(3H,s),5.9
8(1H,br s),6.25(1H,s),6.4
5(1H,s),7.20(2H,d,J=6.0H
z),7.38(1H,br s),8.41(1H,
d,J=6.0Hz). MS(FAB):m/z246(M+H)+ .Under ice cooling, 1.0 ml (10.5 mmol) of 4-pyridinecarboxaldehyde was added dropwise to 8 ml of 6N hydrochloric acid, and then 2,6-dimethyl-p-hydroquinone.1.
59 g (11.5 mmol) was added, and the mixture was stirred at room temperature for 17 hours. 30 ml of water and 20 ml of ethyl acetate were added to the reaction mixture.
ml, and then with vigorous stirring under ice cooling, sodium hydrogen carbonate was added little by little to adjust the pH to 6.5,
The ethyl acetate layer was separated, dried over magnesium sulfate, and the solvent was evaporated under reduced pressure. 50 ml of ethyl acetate was added to the residue,
The mixture was stirred under ice-cooling for 1 hour, and the precipitated crystals were collected by filtration, washed with ethyl acetate and isopropyl ether successively, and dried to give the title compound (2.02 g, yield 79%). Mp: 158-159 Calculated C as ℃ Elemental analysis C 14 H 15 NO 3, 68.56 ; H, 6.16; N, 5.71 Found C, 68.52; H, 6.17; N , 5.66 1 H-NMR (400 MHz, DMSO-d 6 ) δ;
1.88 (3H, s), 2.06 (3H, s), 5.9
8 (1H, br s), 6.25 (1H, s), 6.4
5 (1H, s), 7.20 (2H, d, J = 6.0H
z), 7.38 (1H, br s), 8.41 (1H,
d, J = 6.0 Hz). MS (FAB): m / z 246 (M + H) + .
【0025】実施例43,5−ジメチル−2−(ヒドロキシ−2−ピリジルメ
チル)ベンゼン−1,4−ジオール Example 4 3,5-Dimethyl-2- (hydroxy-2-pyridylme
Chill) benzene-1,4-diol
【0026】[0026]
【化21】 [Chemical 21]
【0027】3−ピリジンカルボキシアルデヒドの代わ
りに、2−ピリジンカルボキシアルデヒド1.0ml
(10.5mmol)を用い、実施例1と同様に処理
し、表記化合物2.00g(収率78%)を得た。 融点:160−161℃ 元素分析値 C14H15NO3 として 計算値 C,68.56;H,6.16;N,5.71 実測値 C,68.57;H,6.14;N,5.721 H−NMR(400MHz,DMSO−d6 )δ;
1.96(3H,s),2.04(3H,s),6.1
−6.2(1H,br s),6.13(1H,s),
6.37(1H,s),7.19(1H,dd,J=
4.8,8.0Hz),7.35(1H,br s),
7.48(1H,d,J=8.0Hz),7.73(1
H,ddd,J=1.8,4.8,8.0Hz),8.
41(1H,dd,J=1.8,4.8Hz),8.9
−9.0(1H,br s). MS(FAB):m/z245(M)+ .Instead of 3-pyridinecarboxaldehyde, 1.0 ml of 2-pyridinecarboxaldehyde
(10.5 mmol) was used and treated in the same manner as in Example 1 to obtain the title compound (2.00 g, yield 78%). Melting point: 160-161 ° C. Elemental analysis value Calculated value as C 14 H 15 NO 3 C, 68.56; H, 6.16; N, 5.71 Actual value C, 68.57; H, 6.14; N , 5.72 1 H-NMR (400MHz , DMSO-d 6) δ;
1.96 (3H, s), 2.04 (3H, s), 6.1
-6.2 (1H, brs), 6.13 (1H, s),
6.37 (1H, s), 7.19 (1H, dd, J =
4.8, 8.0 Hz), 7.35 (1H, br s),
7.48 (1H, d, J = 8.0 Hz), 7.73 (1
H, ddd, J = 1.8, 4.8, 8.0 Hz), 8.
41 (1H, dd, J = 1.8, 4.8Hz), 8.9
-9.0 (1H, brs). MS (FAB): m / z 245 (M) + .
【0028】実施例53,5−ジメチル−2−(イソプロピルオキシ−3−ピ
リジルメチル)ベンゼン−1,4−ジオール塩酸塩 Example 5 3,5-Dimethyl-2- (isopropyloxy-3-pi)
Lysylmethyl) benzene-1,4-diol hydrochloride
【0029】[0029]
【化22】 [Chemical formula 22]
【0030】3−ピリジンカルボキシアルデヒド10g
(93.4mmol)のイソプロピルアルコール(10
0ml)溶液に、氷冷下塩酸ガスを50分間導入し、次
に溶媒を減圧下に留去した。残渣に水、酢酸エチルを加
え炭酸水素ナトリウムで中和し、酢酸エチル層を分液し
た。これを硫酸マグネシウムで乾燥、溶媒を減圧下に留
去後、残渣をシリカゲルカラムクロマトグラフィー(酢
酸エチル:ジクロロメタン=1:3)にて精製し、3−
ピリジンカルボキシアルデヒドジイソプロピルアセター
ル3.44g(収率18%)を得た。1 H−NMR(400MHz,CDCl3 )δ;1.1
8(6H,d,J=6.0Hz),1.21(6H,
d,J=6.0Hz),3.93(2H,qq,J=
6.0,6.0Hz),5.60(1H,s),7.2
9(1H,dd,J=4.8,8.0Hz),7.81
(1H,d,J=8.0Hz),8.57(1H,d,
J=4.8Hz)8.69(1H,s) 上記3−ピリジンカルボキシアルデヒドジイソプロピル
アセタール3.40g(16.2mmol)のイソプロ
ピルアルコール(45ml)の溶液に濃硫酸1.77m
lを滴下し、これに2,6−ジメチル−p−ヒドロキノ
ン3.07g(22.2mmol)を加え、室温で17
時間攪拌した。イソプロピルアルコールを減圧留去し、
残渣に水、酢酸エチルを加え、炭酸水素ナトリウムで中
和し、有機層を分取し、硫酸マグネシウムで乾燥した。
溶媒を減圧下に留去後、残渣をシリカゲルカラムクロマ
トグラフィー(酢酸エチル:n−ヘキサン=2:1)に
て精製し、表記化合物のフリー体2.7g(収率58
%)を得た。このフリー体1.0gを酢酸エチル15m
lに溶かし、氷冷下に4N塩化水素−酢酸エチル1.1
mlを滴下し、10分間攪拌後、析出する結晶を濾取
し、これをアセトニトリル30mlに加熱溶解し、室温
に3時間放置後析出する結晶を濾取し、乾燥し、表記化
合物0.78gを得た。 融点:171−173℃(分解) 元素分析値 C17H21NO3 ・HClとして 計算値 C,63.06;H,6.85;N,4.33 実測値 C,62.96;H,6.74;N,4.341 H−NMR(400MHz,DMSO−d6 )δ;
1.09(3H,d,J=6.0Hz),1.21(3
H,d,J=6.0Hz),1.85(3H,s),
2.09(3H,s),3.62(1H,qq,J=
6.0,6.0Hz),6.36(1H,s),6.5
7(1H,s),7.93(1H,dd,J=5.6,
8.0Hz),8.15(1H,d,J=8.0H
z),8.55(1H,s),8.77(1H,d,J
=5.6Hz). MS(FAB):m/z288(M+H)+ .10 g of 3-pyridinecarboxaldehyde
(93.4 mmol) of isopropyl alcohol (10
Hydrochloric acid gas was introduced into the solution (0 ml) under ice cooling for 50 minutes, and then the solvent was distilled off under reduced pressure. Water and ethyl acetate were added to the residue and the mixture was neutralized with sodium hydrogen carbonate, and the ethyl acetate layer was separated. This was dried over magnesium sulfate, the solvent was evaporated under reduced pressure, and the residue was purified by silica gel column chromatography (ethyl acetate: dichloromethane = 1: 3) to give 3-
3.44 g (yield 18%) of pyridinecarboxaldehyde diisopropyl acetal was obtained. 1 H-NMR (400 MHz, CDCl 3 ) δ; 1.1
8 (6H, d, J = 6.0Hz), 1.21 (6H,
d, J = 6.0 Hz), 3.93 (2H, qq, J =
6.0, 6.0 Hz), 5.60 (1 H, s), 7.2
9 (1H, dd, J = 4.8, 8.0 Hz), 7.81
(1H, d, J = 8.0 Hz), 8.57 (1H, d,
J = 4.8 Hz) 8.69 (1 H, s) 3-pyridinecarboxaldehyde diisopropyl acetal 3.40 g (16.2 mmol) of isopropyl alcohol (45 ml) in a solution of concentrated sulfuric acid 1.77 m.
1 was added dropwise, 3.07 g (22.2 mmol) of 2,6-dimethyl-p-hydroquinone was added thereto, and the mixture was added at room temperature to 17
Stir for hours. Distill off isopropyl alcohol under reduced pressure,
Water and ethyl acetate were added to the residue, the mixture was neutralized with sodium hydrogen carbonate, the organic layer was separated and dried over magnesium sulfate.
After the solvent was distilled off under reduced pressure, the residue was purified by silica gel column chromatography (ethyl acetate: n-hexane = 2: 1), and 2.7 g of the free form of the title compound (yield 58
%) Was obtained. 1.0 g of this free form is converted to 15 m of ethyl acetate.
It was dissolved in 1 l and 4N hydrogen chloride-ethyl acetate 1.1 under ice cooling.
ml was added dropwise, and after stirring for 10 minutes, the precipitated crystal was collected by filtration, dissolved in 30 ml of acetonitrile by heating, and allowed to stand at room temperature for 3 hours, and the precipitated crystal was collected by filtration and dried to obtain 0.78 g of the title compound. Obtained. Melting point: 171-173 ° C. (decomposition) Elemental analysis value Calculated value as C 17 H 21 NO 3 .HCl C, 63.06; H, 6.85; N, 4.33 Actual value C, 62.96; H, 6.74; N, 4.34 1 H- NMR (400MHz, DMSO-d 6) δ;
1.09 (3H, d, J = 6.0Hz), 1.21 (3
H, d, J = 6.0 Hz), 1.85 (3H, s),
2.09 (3H, s), 3.62 (1H, qq, J =
6.0, 6.0 Hz), 6.36 (1H, s), 6.5
7 (1H, s), 7.93 (1H, dd, J = 5.6,
8.0 Hz), 8.15 (1H, d, J = 8.0H
z), 8.55 (1H, s), 8.77 (1H, d, J
= 5.6 Hz). MS (FAB): m / z 288 (M + H) + .
【0031】実施例62−(ヒドロキシ−3−ピリジルメチル)−5−メチル
ベンゼン−1,4−ジオール Example 6 2- (Hydroxy-3-pyridylmethyl) -5-methyl
Benzene-1,4-diol
【0032】[0032]
【化23】 [Chemical formula 23]
【0033】氷冷下、5N塩酸12mlに、3−ピリジ
ンカルボキシアルデヒド1.0ml(11.8ml)の
テトラヒドロフラン(3ml)溶液を滴下し、次いで2
−メチル−p−ヒドロキノン1.46g(11.8m
l)を加え、室温で3日間攪拌した。炭酸水素ナトリウ
ムで中和後酢酸エチルで抽出し、水洗、乾燥し、溶媒を
減圧下に留去した。残渣をシリカゲルカラムクロマトグ
ラフィー(酢酸エチル:ジクロロメタン=1:1)にて
精製し、表記化合物0.45g(収率18%)を得た。
融点:175−176℃(分解)1 H−NMR(400MHz,DMSO−d6 )δ;
1.98(3H,s),5.90(1H,s),6.4
5(1H,s),6.79(1H,s),6.84(1
H,br s),7.27(1H,dd,J=4.8,
8.0Hz),7.61(1H,d,J=8.0H
z),8.35(1H,d,J=4.8Hz),8.4
−8.5(1H,br s),8.50(1H,s),
8.66(1H,s). MS(FAB):m/z232(M+H)+ .Under ice-cooling, a solution of 3-pyridinecarboxaldehyde (1.0 ml, 11.8 ml) in tetrahydrofuran (3 ml) was added dropwise to 12 ml of 5N hydrochloric acid, and then 2
-Methyl-p-hydroquinone 1.46 g (11.8 m
1) was added, and the mixture was stirred at room temperature for 3 days. The mixture was neutralized with sodium hydrogen carbonate, extracted with ethyl acetate, washed with water and dried, and the solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate: dichloromethane = 1: 1) to give the title compound 0.45 g (yield 18%).
Melting point: 175-176 ° C. (decomposition) 1 H-NMR (400 MHz, DMSO-d 6 ) δ;
1.98 (3H, s), 5.90 (1H, s), 6.4
5 (1H, s), 6.79 (1H, s), 6.84 (1
H, br s), 7.27 (1H, dd, J = 4.8,
8.0 Hz), 7.61 (1H, d, J = 8.0H
z), 8.35 (1H, d, J = 4.8Hz), 8.4
-8.5 (1H, brs), 8.50 (1H, s),
8.66 (1H, s). MS (FAB): m / z 232 (M + H) + .
【0034】実施例72−(ヒドロキシ−3−ピリジルメチル)ベンゼン−
1,4−ジオール Example 7 2- (Hydroxy-3-pyridylmethyl) benzene-
1,4-diol
【0035】[0035]
【化24】 [Chemical formula 24]
【0036】2,6−ジメチル−p−ヒドロキノンの代
わりに、p−ヒドロキノン1.95g(17.7mmo
l,アルデヒドに対し1.5eq.)を用い、実施例1
とほぼ同様に処理[室温で43時間反応し、カラムクロ
マトグラフィー(酢酸エチル:ジクロロメタン=1:
1)で精製]し、表記化合物をアモルファスとして0.
80g(収率35%)を得た。1 H−NMR(400MHz,DMSO−d6 )δ;
5.75−5.85(1H,br s),5.91(1
H,s),6.42(1H,dd,J=2.8,8.4
Hz),6.55(1H,d,J=8.4Hz),6.
82(1H,d,J=2.8Hz),7.27(1H,
dd,J=4.8,8.0Hz),7.64(1H,
d,J=8.0Hz),8.36(1H,d,J=4.
8Hz),8.51(1H,s),8.6−8.7(1
H,br s),8.75−8.85(1H,br
s). MS(FAB):m/z218(M+H)+ .Instead of 2,6-dimethyl-p-hydroquinone, 1.95 g (17.7 mmo) of p-hydroquinone
1, eq. ) In Example 1
Almost the same as the above [reacted at room temperature for 43 hours, and subjected to column chromatography (ethyl acetate: dichloromethane = 1: 1).
Purified in 1)], and the title compound as amorphous.
80 g (yield 35%) was obtained. 1 H-NMR (400 MHz, DMSO-d 6 ) δ;
5.75-5.85 (1H, br s), 5.91 (1
H, s), 6.42 (1H, dd, J = 2.8, 8.4
Hz), 6.55 (1H, d, J = 8.4 Hz), 6.
82 (1H, d, J = 2.8 Hz), 7.27 (1H,
dd, J = 4.8, 8.0 Hz), 7.64 (1H,
d, J = 8.0 Hz), 8.36 (1H, d, J = 4.
8 Hz), 8.51 (1 H, s), 8.6-8.7 (1
H, br s), 8.75-8.85 (1H, br
s). MS (FAB): m / z 218 (M + H) + .
【0037】実施例83,5−ジメチル−2−(エトキシ−3−ピリジルメチ
ル)ベンゼン−1,4−ジオール塩酸塩 Example 8 3,5-Dimethyl-2- (ethoxy-3-pyridylmethyi)
Le) Benzene-1,4-diol hydrochloride
【0038】[0038]
【化25】 [Chemical 25]
【0039】3−ピリジンカルボキシアルデヒド1.6
ml(16.5mmol)の20%(w/w)塩酸−エ
タノール溶液25mlに、2,6−ジメチル−p−ヒド
ロキノン2.5g(18.1mmol)を加え、室温で
23時間攪拌した。エタノールを減圧留去後、残渣に
水、酢酸エチルを加え、炭酸水素ナトリウムで中和し、
有機層を分取し、硫酸マグネシウムで乾燥した。溶媒を
減圧下に留去後、残渣をシリカゲルカラムクロマトグラ
フィー(酢酸エチル:n−ヘキサン=1:1)にて精製
し、表記化合物のフリー体3.2g(収率71%)を得
た。このうち1.7gを酢酸エチル33mlに溶解し、
氷冷下に4N塩化水素−酢酸エチル1.8mlを滴下
し、10分間攪拌した。析出する結晶を濾取し、アセト
ニトリル60mlを加え10分間加熱還流後、室温で1
時間攪拌し、析出物を濾取して、アセトニトリル、イソ
プロピルエーテルで順次洗浄し、乾燥して表記化合物
1.1gを得た。 融点:185−187℃(分解) 元素分析値 C16H19NO3 ・HClとして 計算値 C,62.03;H,6.51;N,4.52 実測値 C,61.96;H,6.59;N,4.561 H−NMR(400MHz,DMSO−d6 )δ;
1.18(3H,t,J=6.8),1.88(3H,
s),2.08(3H,s),3.47(3H、m),
6.24(1H,s),6.56(1H,s),7.9
3(1H,dd,J=5.6,8.0Hz),8.17
(1H,d,J=8.0Hz),8.58(1H,
s),8.76(1H,d,J=5.6Hz). MS(FAB):m/z274(M+H)+ .3-Pyridinecarboxaldehyde 1.6
2.5 g (18.1 mmol) of 2,6-dimethyl-p-hydroquinone was added to 25 ml of 20% (w / w) hydrochloric acid-ethanol solution of ml (16.5 mmol), and the mixture was stirred at room temperature for 23 hours. After ethanol was distilled off under reduced pressure, water and ethyl acetate were added to the residue and neutralized with sodium hydrogen carbonate.
The organic layer was separated and dried over magnesium sulfate. After evaporating the solvent under reduced pressure, the residue was purified by silica gel column chromatography (ethyl acetate: n-hexane = 1: 1) to obtain 3.2 g of the free form of the title compound (yield 71%). 1.7 g of this was dissolved in 33 ml of ethyl acetate,
1.8 ml of 4N hydrogen chloride-ethyl acetate was added dropwise under ice cooling, and the mixture was stirred for 10 minutes. The precipitated crystals were collected by filtration, added with 60 ml of acetonitrile and heated under reflux for 10 minutes, then at room temperature for 1 hour.
After stirring for an hour, the precipitate was collected by filtration, washed successively with acetonitrile and isopropyl ether, and dried to give 1.1 g of the title compound. Melting point: 185-187 ° C. (decomposition) Elemental analysis value Calculated value as C 16 H 19 NO 3 .HCl C, 62.03; H, 6.51; N, 4.52 Measured value C, 61.96; H, 6.59; N, 4.56 1 H-NMR (400 MHz, DMSO-d 6 ) δ;
1.18 (3H, t, J = 6.8), 1.88 (3H,
s), 2.08 (3H, s), 3.47 (3H, m),
6.24 (1H, s), 6.56 (1H, s), 7.9
3 (1H, dd, J = 5.6, 8.0 Hz), 8.17
(1H, d, J = 8.0 Hz), 8.58 (1H,
s), 8.76 (1H, d, J = 5.6 Hz). MS (FAB): m / z 274 (M + H) + .
【0040】実施例93,5−ジメチル−2−(ヒドロキシ−6−メチルピリ
ジルメチル)ベンゼン−1,4−ジオール Example 9 3,5-Dimethyl-2- (hydroxy-6-methylpyrrole)
Dilmethyl) benzene-1,4-diol
【0041】[0041]
【化26】 [Chemical formula 26]
【0042】3−ピリジンカルボキシアルデヒドの代り
に6−メチル−2−ピリジンカルボキシアルデヒドを用
い、実施例1と同様に処理して、表記化合物を88%の
収率で得た。 融点:176−178℃(分解) 元素分析値C15H17NO3 ・0.36H2 Oとして 計算値 C,67.78;H,6.72;N,5.27 実測値 C,67.77;H,6.70;N,5.221 H−NMR(400MHz,DMSO−d6 )δ;
2.00(3H,s),2.05(3H,s),2.4
5(3H,s),6.10(1H,s),6.2(1
H,br s),6.38(1H、s),7.18(1
H,br s),7.22(1H,d,J=8.0H
z),7.41(1H,s),7.7(1H,br
s). MS(FAB):m/z259(M+H)+ .Using 6-methyl-2-pyridinecarboxaldehyde in place of 3-pyridinecarboxaldehyde and treating in the same manner as in Example 1, the title compound was obtained in 88% yield. Mp: 176-178 ° C. (decomposition) Elemental analysis C 15 H 17 NO 3 · 0.36H 2 O Calculated C, 67.78; H, 6.72; N, 5.27 Found C, 67. 77; H, 6.70; N, 5.22 1 H-NMR (400MHz, DMSO-d 6) δ;
2.00 (3H, s), 2.05 (3H, s), 2.4
5 (3H, s), 6.10 (1H, s), 6.2 (1
H, br s), 6.38 (1H, s), 7.18 (1
H, br s), 7.22 (1H, d, J = 8.0H
z), 7.41 (1H, s), 7.7 (1H, br
s). MS (FAB): m / z 259 (M + H) + .
【0043】実施例103,5−ジメチル−2−(ヒドロキシ−4−クロロピリ
ジルメチル)ベンゼン−1,4−ジオール Example 10 3,5-Dimethyl-2- (hydroxy-4-chloropyrpyrene)
Dilmethyl) benzene-1,4-diol
【0044】[0044]
【化27】 [Chemical 27]
【0045】3−ピリジンカルボキシアルデヒドの代り
に6−クロロ−2−ピリジンカルボキシアルデヒドを用
い、実施例1と同様に処理して、表記化合物を89%の
収率で得た。 融点:155−157℃(分解) 元素分析値C14H14NO3 Clとして 計算値 C,60.11;H,5.04;N,5.01 実測値 C,59.94;H,5.16;N,5.031 H−NMR(400MHz,DMSO−d6 )δ;
1.95(3H,s),2.04(3H,s),6.1
(2H,b),6.36(1H,s),7.33(1
H,dd,J=2.0,5.2Hz),7.37(1
H,s),7.61(1H,d,J=2.0Hz),
8.36(1H,d,J=5.2Hz).8.75 (1H,s).MS(FAB):m/z279(M)
+ .By using 6-chloro-2-pyridinecarboxaldehyde in place of 3-pyridinecarboxaldehyde and treating in the same manner as in Example 1, the title compound was obtained in a yield of 89%. Mp: 155-157 ° C. (decomposition) Elemental analysis C 14 H 14 NO 3 Calculated C as Cl, 60.11; H, 5.04; N, 5.01 Found C, 59.94; H, 5 .16; N, 5.03 1 H-NMR (400 MHz, DMSO-d 6 ) δ;
1.95 (3H, s), 2.04 (3H, s), 6.1
(2H, b), 6.36 (1H, s), 7.33 (1
H, dd, J = 2.0, 5.2 Hz), 7.37 (1
H, s), 7.61 (1H, d, J = 2.0 Hz),
8.36 (1H, d, J = 5.2 Hz). 8.75 (1H, s). MS (FAB): m / z 279 (M)
+ .
【0046】実施例112−(ヒドロキシ−3−ピリジルメチル)−3,5,6
−トリメチルベンゼン−1,4−ジオール Example 11 2- (Hydroxy-3-pyridylmethyl) -3,5,6
-Trimethylbenzene-1,4-diol
【0047】[0047]
【化28】 [Chemical 28]
【0048】2,6−ジメチル−p−ヒドロキノンの代
わりに2,3,5−トリメチル−p−ヒドロキノンを用
い、実施例1と同様に処理して、表記化合物を86%の
収率で得た。 融点:206−207℃(分解) 元素分析値C15H17NO3 として 計算値 C,69.48;H,6.61;N,5.40 実測値 C,69.43;H,6.64;N,5.351 H−NMR(400MHz,DMSO−d6 )δ;
1.98(3H,s),2.02(3H,s),2.0
6(3H,s),6.18(1H,s),7.1(1
H,s),7.31(1H,dd,J=4.8,8.0
Hz),7.4(1H,br s),7.59(1H,
d,J=8.0Hz),8.41(1H,d,J=4.
8Hz),8.46(1H,s),8.9(1H,br
s). MS(FAB):m/z260(M+H)+ .2,3,5-Trimethyl-p-hydroquinone was used in place of 2,6-dimethyl-p-hydroquinone and treated in the same manner as in Example 1 to obtain the title compound in a yield of 86%. . Melting point: 206-207 ° C (decomposition) Elemental analysis value Calculated value as C 15 H 17 NO 3 C, 69.48; H, 6.61; N, 5.40 Measured value C, 69.43; H, 6. 64; N, 5.35 1 H- NMR (400MHz, DMSO-d 6) δ;
1.98 (3H, s), 2.02 (3H, s), 2.0
6 (3H, s), 6.18 (1H, s), 7.1 (1
H, s), 7.31 (1H, dd, J = 4.8, 8.0
Hz), 7.4 (1H, br s), 7.59 (1H,
d, J = 8.0 Hz), 8.41 (1H, d, J = 4.
8Hz), 8.46 (1H, s), 8.9 (1H, br
s). MS (FAB): m / z 260 (M + H) + .
【0049】実施例123,5−ジメチル−2−(ヒドロキシ−3−ピリジルメ
チル)−1,4−ベンゾキノン塩酸塩 Example 12 3,5-Dimethyl-2- (hydroxy-3-pyridylme)
Chill) -1,4-benzoquinone hydrochloride
【0050】[0050]
【化29】 [Chemical 29]
【0051】3,5−ジメチル−2−(ヒドロキシ−3
−ピリジルメチル)ベンゼン−1,4−ジオール30g
(0.12mol)を水(60ml)とテトラヒドロフ
ラン(60ml)の溶液に溶かし、氷冷下攪拌しながら
濃硝酸78mlを15分間で滴下した。5分後酢酸エチ
ル450mlと水60mlを加え、次に炭酸ナトリウム
64gの水(250ml)溶液、炭酸水素ナトリウム1
7.3gを加えて中和した。次に酢酸エチル層を分液
し、水、飽和食塩水で洗浄、硫酸マグネシウムで乾燥し
た。硫酸マグネシウムを除去後、この酢酸エチル溶液に
氷冷下4N塩化水素−酢酸エチル33.7mlを滴下
し、15分間攪拌した。析出結晶を濾取し、酢酸エチ
ル、イソプロピルエーテルで洗浄、乾燥し表記化合物3
0.4g(収率90%)を得た。 融点:155−160℃(分解)1 H−NMR(400MHz,DMSO−d6 )δ;
1.97(3H,d,J=1.6Hz),1.98(3
H,s),6.14(1H,s),6.68(1H,
d,J=1.6Hz),7.95(1H,dd,J=
5.6,8.0Hz),8.40(1H,d,J=8.
0Hz),8.76(1H,s),8.77(1H,
d,J=5.6Hz). MS(FAB):m/z244(M+ +H).3,5-dimethyl-2- (hydroxy-3)
-Pyridylmethyl) benzene-1,4-diol 30 g
(0.12 mol) was dissolved in a solution of water (60 ml) and tetrahydrofuran (60 ml), and 78 ml of concentrated nitric acid was added dropwise over 15 minutes while stirring under ice cooling. After 5 minutes, 450 ml of ethyl acetate and 60 ml of water were added, and then a solution of 64 g of sodium carbonate in water (250 ml) and sodium hydrogen carbonate 1
7.3g was added and neutralized. Next, the ethyl acetate layer was separated, washed with water and saturated brine, and dried over magnesium sulfate. After removing magnesium sulfate, 33.7 ml of 4N hydrogen chloride-ethyl acetate was added dropwise to this ethyl acetate solution under ice cooling, and the mixture was stirred for 15 minutes. The precipitated crystals were collected by filtration, washed with ethyl acetate and isopropyl ether and dried to give the title compound 3
0.4 g (yield 90%) was obtained. Melting point: 155-160 ° C. (decomposition) 1 H-NMR (400 MHz, DMSO-d 6 ) δ;
1.97 (3H, d, J = 1.6Hz), 1.98 (3
H, s), 6.14 (1H, s), 6.68 (1H,
d, J = 1.6 Hz), 7.95 (1H, dd, J =
5.6, 8.0 Hz, 8.40 (1H, d, J = 8.
0 Hz), 8.76 (1H, s), 8.77 (1H,
d, J = 5.6 Hz). MS (FAB): m / z244 (M + + H).
【0052】実施例133,5−ジメチル−2−(メトキシ−3−ピリジルメチ
ル)−1,4−ベンゾキノン Example 13 3,5-Dimethyl-2- (methoxy-3-pyridylmethyi)
) -1,4-benzoquinone
【0053】[0053]
【化30】 [Chemical 30]
【0054】3,5−ジメチル−2−(メトキシ−3−
ピリジルメチル)ベンゼン−1,4−ジオール塩酸塩
1.0g(3.38mmol)を水(3ml)とテトラ
ヒドロフラン(2ml)に溶かし、氷冷下濃硝酸3ml
を5分間で滴下した。5分後酢酸エチル15mlと水2
mlを加え、炭酸ナトリウム、飽和炭酸水素ナトリウム
水溶液を加えて中和した。酢酸エチル層を分液し、水、
飽和食塩水で洗浄、硫酸マグネシウムで乾燥後、減圧下
に溶媒を留去し油状物として表記化合物1.0g(収率
100%)を得た。1 H−NMR(400MHz,CDCl3 )δ;2.0
7(3H,d,J=1.6Hz),2.10(3H,
s),3.42(3H,s),5.90(1H,s),
6.63(1H,d,J=1.6Hz),7.26(1
H,dd,J=4.8,8.0Hz),7.68(1
H,d,J=8.0Hz),8.50(1H,d,J=
4.8Hz),8.56(1H,s).3,5-dimethyl-2- (methoxy-3-)
Pyridylmethyl) benzene-1,4-diol hydrochloride (1.0 g, 3.38 mmol) was dissolved in water (3 ml) and tetrahydrofuran (2 ml), and ice-cooled concentrated nitric acid (3 ml) was added.
Was added dropwise over 5 minutes. After 5 minutes 15 ml of ethyl acetate and 2 of water
ml was added, and sodium carbonate and saturated aqueous sodium hydrogen carbonate solution were added to neutralize. The ethyl acetate layer was separated, water,
The extract was washed with saturated brine and dried over magnesium sulfate, and the solvent was evaporated under reduced pressure to give the title compound (1.0 g, yield 100%) as an oil. 1 H-NMR (400 MHz, CDCl 3 ) δ; 2.0
7 (3H, d, J = 1.6Hz), 2.10 (3H,
s), 3.42 (3H, s), 5.90 (1H, s),
6.63 (1H, d, J = 1.6Hz), 7.26 (1
H, dd, J = 4.8, 8.0 Hz), 7.68 (1
H, d, J = 8.0 Hz), 8.50 (1H, d, J =
4.8 Hz), 8.56 (1 H, s).
【0055】実施例143,5−ジメチル−2−(イソプロピルオキシ−3−ピ
リジルメチル)−1,4−ベンゾキノン塩酸塩 Example 14 3,5-Dimethyl-2- (isopropyloxy-3-pi)
Lysylmethyl) -1,4-benzoquinone hydrochloride
【0056】[0056]
【化31】 [Chemical 31]
【0057】3,5−ジメチル−2−(イソプロピルオ
キシ−3−ピリジルメチル)ベンゼン−1,4−ジオー
ル2.3g(8.01mmol)を酢酸エチル34.5
mlに溶かし、塩化第二鉄・六水和物(FeCl3 ・6
H2 O)4.33g(16.03mmol)の水(10
ml)溶液を加え2分間激しく攪拌した。反応終了後氷
冷下に炭酸水素ナトリウム3.37g(40.1mmo
l)を加え、セライトを引いて濾過し不溶物を除いた。
次いで濾液を酢酸エチルで抽出し、水、飽和食塩水で洗
浄後、酢酸エチル層を硫酸マグネシウムで乾燥し、硫酸
マグネシウムを除いた後、この酢酸エチル溶液に4N塩
化水素−酢酸エチル9.6mlを滴下し、溶媒を減圧下
に留去し、表記化合物2.3g(収率89%)を得た。1 H−NMR(400MHz,CDCl3 )δ;1.2
0(3H,d,J=6.0Hz),1.24(3H,
d,J=6.0Hz),2.00(3H,s),2.0
9(3H,d,J=1.6Hz),3.72(1H,q
q,J=6.0,6.0Hz),6.21(1H,
s),6.67(1H,d,J=1.6Hz),7.8
7(1H,dd,J=5.6,8.0Hz),8.30
(1H,d,J=8.0Hz),8.67(1H,d,
J=5.6Hz),8.77(1H,s).2.3 g (8.01 mmol) of 3,5-dimethyl-2- (isopropyloxy-3-pyridylmethyl) benzene-1,4-diol was added to 34.5 of ethyl acetate.
Dissolve ml, and ferric chloride hexahydrate (FeCl 3 · 6
H 2 O) water 4.33g (16.03mmol) (10
ml) solution was added and vigorously stirred for 2 minutes. After the reaction was completed, under cooling with ice, 3.37 g (40.1 mmo) of sodium hydrogencarbonate was obtained.
l) was added, and Celite was pulled and filtered to remove insoluble matter.
Then, the filtrate was extracted with ethyl acetate, washed with water and saturated saline, and the ethyl acetate layer was dried over magnesium sulfate to remove magnesium sulfate, and then 4N hydrogen chloride-ethyl acetate (9.6 ml) was added to the ethyl acetate solution. The solvent was distilled off under reduced pressure to obtain 2.3 g (yield 89%) of the title compound. 1 H-NMR (400 MHz, CDCl 3 ) δ; 1.2
0 (3H, d, J = 6.0Hz), 1.24 (3H,
d, J = 6.0 Hz), 2.00 (3H, s), 2.0
9 (3H, d, J = 1.6Hz), 3.72 (1H, q
q, J = 6.0, 6.0 Hz), 6.21 (1H,
s), 6.67 (1H, d, J = 1.6Hz), 7.8
7 (1H, dd, J = 5.6, 8.0 Hz), 8.30
(1H, d, J = 8.0 Hz), 8.67 (1H, d,
J = 5.6 Hz), 8.77 (1H, s).
【0058】実施例153,5−ジメチル−2−(ヒドロキシ−3−ピリジルメ
チル)−1,4−ベンゾキノン塩酸塩 3,5−ジメチル−2−(ヒドロキシ−3−ピリジルメ
チル)ベンゼン−1,4−ジオール0.5g(2.04
mmol)を水1.0mlとメタノール(3.0ml)
の溶液に溶かし、塩化第二銅・二水和物(CuCl2 ・
2H2 O)17mgを加え、空気を吹き込みながら、1
時間半攪拌した。反応液に酢酸エチル15ml、水10
mlを加えた後、飽和炭酸水素ナトリウム溶液を加えて
pH7に調整した。酢酸エチル層を分液し、水、飽和食
塩水で洗浄、硫酸マグネシウムで乾燥した。硫酸ンマグ
ネシウムを除去後、この酢酸エチル溶液に氷冷下4N塩
化水素−酢酸エチル0.56mlを滴下し、15分間攪
拌した。析出結晶を濾取し、酢酸エチル、イソプロピル
エーテルで洗浄、乾燥し表記化合物0.46g(収率8
1%)を得た。融点並びに1 H−NMRスペクトルは実
施例12の化合物と一致した。Example 15 3,5-Dimethyl-2- (hydroxy-3-pyridylme
Cyl) -1,4-benzoquinone hydrochloride 3,5-dimethyl-2- (hydroxy-3-pyridylmethyl) benzene-1,4-diol 0.5 g (2.04
mmol) 1.0 ml of water and methanol (3.0 ml)
Dissolved in a solution of cupric chloride dihydrate (CuCl 2
2H 2 O) 17 mg, and while blowing in air, 1
Stir for half an hour. 15 ml of ethyl acetate and 10 parts of water in the reaction solution
After adding ml, the pH was adjusted to 7 by adding saturated sodium hydrogen carbonate solution. The ethyl acetate layer was separated, washed with water and saturated brine, and dried over magnesium sulfate. After removing magnesium sulfate, 0.56 ml of 4N hydrogen chloride-ethyl acetate was added dropwise to this ethyl acetate solution under ice cooling, and the mixture was stirred for 15 minutes. The precipitated crystals were collected by filtration, washed with ethyl acetate and isopropyl ether and dried to give 0.46 g of the title compound (yield 8
1%) was obtained. The melting point and 1 H-NMR spectrum were consistent with those of the compound of Example 12.
【0059】応用例 次に、本発明で得られたキノン化合物より医薬として有
用な2−アミノ−6−ヒドロキシ−4−ピリジルメチル
ベンゾチアゾール化合物を合成する例を示す。 Application Example Next, an example of synthesizing a 2-amino-6-hydroxy-4-pyridylmethylbenzothiazole compound useful as a medicine from the quinone compound obtained in the present invention will be shown.
【0060】応用例1 5,7−ジメチル−6−ヒドロキシ−2−メチルアミノ
−4−[(3−ピリジル)ヒドロキシメチル]ベンゾチ
アゾール Application Example 1 5,7-Dimethyl-6-hydroxy-2-methylamino
-4-[(3-pyridyl) hydroxymethyl] benzothi
Azole
【0061】[0061]
【化32】 [Chemical 32]
【0062】3,5−ジメチル−2−(ヒドロキシ−3
−ピリジルメチル)−1,4−ベンゾキノン塩酸塩(実
施例12)30g(0.11mol)のエタノール30
0mlの懸濁液に、濃塩酸21.7mlとメチルチオ尿
素9.68g(0.11mol)を氷冷下に加えて、4
℃で15時間攪拌した(反応混合物は一度溶解し、次に
析出物が徐々に増加した)。酢酸エチル300mlを加
え、10分間攪拌後、析出物を濾取し、酢酸エチル、イ
ソプロピルエーテルで洗浄して、チウロニウム塩を得
た。このエタノールの300ml懸濁液に、テトラヒド
ロフラン23.8mlに溶解した1,4−ベンゾキノン
2.9gを氷冷下に加えて、4℃で4時間、20℃で3
時間攪拌した。次に酢酸エチル300mlを加え、10
分間攪拌後、析出物を濾取し、酢酸エチル、イソプロピ
ルエーテルで洗浄し、乾燥して表題化合物の塩酸塩3
6.3gを得た。これを、水524mlに溶解し 、酢酸
エチル、イソプロピルエーテルで洗浄し、五酸化リンの
存在下に乾燥して表題化合物26.9g(収率80%)
を得た。 融点:201−203℃(分解) H−NMR(400MHz,DMSO−d6 )δ:2.
03(3H,s),2.21(3H,s),2.88
(3H,d,J=4.8Hz),6.51(1H,d,
J=6.6Hz),6.55(1H,d,J=6.6H
z),7.27(1H,dd,J=4.8,8.0H
z),7.60(1H,d,J=8.0Hz),7.8
2(1H,d,J=4.8Hz),7.97(1H,
s),8.35(1H,d,J=4.8Hz),8.4
6(1H,s). MS(FAB):m/z316(M+H)+ .応用例2 5,7−ジメチル−6−ヒドロキシ−2−メチルアミノ
−4−[(3−ピリジル)メチル]ベンゾチアゾール 3,5-dimethyl-2- (hydroxy-3)
-Pyridylmethyl) -1,4-benzoquinone hydrochloride (Example 12) 30 g (0.11 mol) of ethanol 30
To the 0 ml suspension, 21.7 ml of concentrated hydrochloric acid and 9.68 g (0.11 mol) of methylthiourea were added under ice cooling, and
Stir for 15 h at 0 ° C. (reaction mixture once dissolved, then precipitate gradually increased). After adding 300 ml of ethyl acetate and stirring for 10 minutes, the precipitate was collected by filtration and washed with ethyl acetate and isopropyl ether to obtain a thiuronium salt. To this 300 ml suspension of ethanol, 2.9 g of 1,4-benzoquinone dissolved in 23.8 ml of tetrahydrofuran was added under ice cooling, and the mixture was kept at 4 ° C. for 4 hours and at 20 ° C. for 3 hours.
Stir for hours. Next, add 300 ml of ethyl acetate and add 10
After stirring for 1 minute, the precipitate was collected by filtration, washed with ethyl acetate and isopropyl ether, and dried to give the hydrochloride of the title compound 3
6.3 g was obtained. This was dissolved in 524 ml of water, washed with ethyl acetate and isopropyl ether, and dried in the presence of phosphorus pentoxide to give 26.9 g of the title compound (yield 80%).
Got Melting point: 201-203 ° C. (decomposition) H-NMR (400 MHz, DMSO-d 6 ) δ: 2.
03 (3H, s), 2.21 (3H, s), 2.88
(3H, d, J = 4.8Hz), 6.51 (1H, d,
J = 6.6 Hz), 6.55 (1H, d, J = 6.6H)
z), 7.27 (1H, dd, J = 4.8, 8.0H
z), 7.60 (1H, d, J = 8.0 Hz), 7.8
2 (1H, d, J = 4.8Hz), 7.97 (1H,
s), 8.35 (1H, d, J = 4.8Hz), 8.4
6 (1H, s). MS (FAB): m / z 316 (M + H) + . Application Example 2 5,7-Dimethyl-6-hydroxy-2-methylamino
-4-[(3-pyridyl) methyl] benzothiazole
【0063】[0063]
【化33】 [Chemical 33]
【0064】5,7−ジメチル−6−ヒドロキシ−2−
メチルアミノ−4−[(3−ピリジル)ヒドロキシメチ
ル]ベンゾチアゾール5.0g(15.9mmol)の
酢酸50ml溶液に、亜鉛末2.6g(39.8mmo
l)を加え26時間加熱還流を行った。熱時不溶物を濾
去後、酢酸エチル200mlを加え、氷冷下に10分間
攪拌し析出物を濾取した。これをエタノール100ml
に溶解し、氷冷下に4N塩酸−酢酸エチル溶液24ml
を滴下し、30分間攪拌後、析出物を濾取し、酢酸エチ
ル、イソプロピルエーテルで洗浄し、乾燥して表題化合
物の塩酸塩5.9gを得た。これを、水100mlに溶
解し 、酢酸エチル75mlを加え、氷冷下に飽和炭酸水素ナ
トリウム水溶液を加えて中和し、析出物を濾取した。さ
らに析出物をエタノール75mlに懸濁させ1時間加熱還流
した後、氷冷下に15分攪拌後結晶を濾取し、エタノー
ルで洗浄、乾燥して表題化合物2.9g(収率61%)
を得た。 融点:220−223℃(分解)1 H−NMR(400MHz,DMSO−d6 )δ:
2.07(3H,s),2.20(3H,s),2.8
7(3H,d,J=4.8Hz),4.25(2H,
s),7.20(1H,dd,J=4.8,8.0H
z),7.48(1H,d,J=8.0Hz),7.6
5(1H,d,J=4.8Hz),7.90(1H,b
r),8.31(1H,s),8.46(1H,s).5,7-Dimethyl-6-hydroxy-2-
To a solution of 5.0 g (15.9 mmol) of methylamino-4-[(3-pyridyl) hydroxymethyl] benzothiazole in 50 ml of acetic acid, 2.6 g (39.8 mmo) of zinc powder was added.
1) was added and the mixture was heated under reflux for 26 hours. After the insoluble matter was filtered off while hot, 200 ml of ethyl acetate was added, and the mixture was stirred under ice cooling for 10 minutes and the precipitate was collected by filtration. 100 ml of ethanol
Dissolve in, and under ice-cooling, 24 ml of 4N hydrochloric acid-ethyl acetate solution
Was added dropwise and the mixture was stirred for 30 minutes, then the precipitate was collected by filtration, washed with ethyl acetate and isopropyl ether, and dried to obtain 5.9 g of the hydrochloride of the title compound. This was dissolved in 100 ml of water, 75 ml of ethyl acetate was added, and saturated aqueous sodium hydrogencarbonate solution was added under ice cooling to neutralize, and the precipitate was collected by filtration. Further, the precipitate was suspended in 75 ml of ethanol, heated under reflux for 1 hour, stirred under ice-cooling for 15 minutes, then the crystals were collected by filtration, washed with ethanol and dried to give the title compound (2.9 g, yield 61%).
Got Melting point: 220-223 ° C. (decomposition) 1 H-NMR (400 MHz, DMSO-d 6 ) δ:
2.07 (3H, s), 2.20 (3H, s), 2.8
7 (3H, d, J = 4.8Hz), 4.25 (2H,
s), 7.20 (1H, dd, J = 4.8, 8.0H
z), 7.48 (1H, d, J = 8.0 Hz), 7.6
5 (1H, d, J = 4.8Hz), 7.90 (1H, b
r), 8.31 (1H, s), 8.46 (1H, s).
───────────────────────────────────────────────────── フロントページの続き (72)発明者 西村 博 茨城県鹿島郡波崎町太田新田1−3−4 (72)発明者 山岸 洋二 茨城県新治郡千代田町上稲吉2010−46 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Hiroshi Nishimura 1-3-4 Ota-shinta, Hasaki-cho, Kashima-gun, Ibaraki Prefecture (72) Inventor Yoji Yamagishi Kaminakichi, Chiyoda-cho, Shinji-gun, Ibaraki 2010-46
Claims (10)
を、R2 およびR3 は同一または異なって水素原子また
はメチル基を意味する)で表されるヒドロキノン誘導体
と一般式(II)あるいは一般式(II’) 【化2】 (式中、Xは水素原子、低級アルキル基、低級アルコキ
シ基またはハロゲン原子を、R’は低級アルキル基を意
味する)で表されるアルデヒド誘導体を酸の存在下に縮
合することを特徴とする一般式(III) 【化3】 (式中、R1 は水素原子、メチル基またはメトキシ基
を、R2 およびR3 は同一または異なって水素原子また
はメチル基を、R4 は水素原子または低級アルキル基
を、Xは水素原子、低級アルキル基、低級アルコキシ基
またはハロゲン原子を意味する)で表されるヒドロキノ
ン誘導体またはその塩の製造方法。1. A compound of the general formula (I) (Wherein R 1 represents a hydrogen atom, a methyl group or a methoxy group, and R 2 and R 3 are the same or different and represent a hydrogen atom or a methyl group) and a hydroquinone derivative represented by the general formula (II) or Formula (II ′) embedded image (Wherein, X represents a hydrogen atom, a lower alkyl group, a lower alkoxy group or a halogen atom, and R ′ represents a lower alkyl group), and the aldehyde derivative is condensed in the presence of an acid. General formula (III): (In the formula, R 1 is a hydrogen atom, a methyl group or a methoxy group, R 2 and R 3 are the same or different and are a hydrogen atom or a methyl group, R 4 is a hydrogen atom or a lower alkyl group, X is a hydrogen atom, (Meaning a lower alkyl group, a lower alkoxy group or a halogen atom), and a method for producing a hydroquinone derivative or a salt thereof.
を、R2 およびR3 は同一または異なって水素原子また
はメチル基を、R4 は水素原子または低級アルキル基
を、Xは水素原子、低級アルキル基、低級アルコキシ基
またはハロゲン原子を意味する)で表されるヒドロキノ
ン誘導体を酸化することを特徴とする一般式(IV) 【化5】 (式中、R1 は水素原子、メチル基またはメトキシ基
を、R2 およびR3 は同一または異なって水素原子また
はメチル基を、R4 は水素原子または低級アルキル基
を、Xは水素原子、低級アルキル基、低級アルコキシ基
またはハロゲン原子を意味する)で表される1,4−ベ
ンゾキノン誘導体またはその塩の製造方法。2. A compound represented by the general formula (III): (In the formula, R 1 is a hydrogen atom, a methyl group or a methoxy group, R 2 and R 3 are the same or different and are a hydrogen atom or a methyl group, R 4 is a hydrogen atom or a lower alkyl group, X is a hydrogen atom, A lower alkyl group, a lower alkoxy group or a halogen atom) is oxidized to oxidize a hydroquinone derivative represented by the general formula (IV): (In the formula, R 1 is a hydrogen atom, a methyl group or a methoxy group, R 2 and R 3 are the same or different and are a hydrogen atom or a methyl group, R 4 is a hydrogen atom or a lower alkyl group, X is a hydrogen atom, Which means a lower alkyl group, a lower alkoxy group or a halogen atom), and a method for producing a 1,4-benzoquinone derivative or a salt thereof.
子またはメチル基を意味し、R2 およびXが水素原子で
ある請求項1記載のヒドロキノン誘導体またはその塩の
製造方法。3. A compound represented by the general formula (III): In the above, R 1 and R 3 are the same or different and each represents a hydrogen atom or a methyl group, and R 2 and X are hydrogen atoms, and the method for producing a hydroquinone derivative or a salt thereof according to claim 1.
子またはメチル基を意味し、R2 およびXが水素原子で
ある請求項2記載の1,4−ベンゾキノン誘導体または
その塩の製造方法。4. A compound represented by the general formula (IV): Wherein R 1 and R 3 are the same or different and each represents a hydrogen atom or a methyl group, and R 2 and X are hydrogen atoms, and the method for producing a 1,4-benzoquinone derivative or a salt thereof according to claim 2.
を、R2 およびR3 は同一または異なって水素原子また
はメチル基を、R4 は水素原子または低級アルキル基
を、Xは水素原子、低級アルキル基、低級アルコキシ基
またはハロゲン原子を意味する)で表される請求項3記
載のヒドロキノン誘導体およびその塩。5. A compound represented by the general formula (III): (In the formula, R 1 is a hydrogen atom, a methyl group or a methoxy group, R 2 and R 3 are the same or different and are a hydrogen atom or a methyl group, R 4 is a hydrogen atom or a lower alkyl group, X is a hydrogen atom, (Meaning a lower alkyl group, a lower alkoxy group or a halogen atom), and the hydroquinone derivative or a salt thereof according to claim 3.
を、R2 およびR3 は同一または異なって水素原子また
はメチル基を、R4 は水素原子または低級アルキル基
を、Xは水素原子、低級アルキル基、低級アルコキシ基
またはハロゲン原子を意味する)で表される請求項4記
載の1,4−ベンゾキノン誘導体およびその塩。6. A compound represented by the general formula (IV): (In the formula, R 1 is a hydrogen atom, a methyl group or a methoxy group, R 2 and R 3 are the same or different and are a hydrogen atom or a methyl group, R 4 is a hydrogen atom or a lower alkyl group, X is a hydrogen atom, (Meaning a lower alkyl group, a lower alkoxy group or a halogen atom), and the 1,4-benzoquinone derivative or a salt thereof according to claim 4.
水素原子である請求項1記載のヒドロキノン誘導体およ
びその塩。7. A compound represented by the general formula (III): 2. The hydroquinone derivative and salt thereof according to claim 1 , wherein R 1 and R 3 are methyl groups, and R 2 and X are hydrogen atoms.
水素原子である請求項4記載の1,4−ベンゾキノン誘
導体誘導体およびその塩。8. A compound represented by the general formula (IV): The 1,4-benzoquinone derivative derivative or a salt thereof according to claim 4, wherein R 1 and R 3 are methyl groups, and R 2 and X are hydrogen atoms.
導体と一般式(II)あるいは一般式(II’)で表さ
れるアルデヒド誘導体を酸の存在下に縮合し、得られた
一般式(III)で表されるヒドロキノン誘導体または
その塩を酸化することを特徴とする一般式(IV)で表
される1,4−ベンゾキノン誘導体またはその塩の製造
方法。 【化12】 (式中、R1 は水素原子、メチル基またはメトキシ基
を、R2 およびR3 は同一または異なって水素原子また
はメチル基を、R’は低級アルキル基を、R4 は水素原
子または低級アルキル基を、Xは水素原子、低級アルキ
ル基、低級アルコキシ基またはハロゲン原子を意味す
る)。9. A hydroquinone derivative represented by the general formula (I) and an aldehyde derivative represented by the general formula (II) or (II ′) are condensed in the presence of an acid to obtain a general formula ( A method for producing a 1,4-benzoquinone derivative represented by the general formula (IV) or a salt thereof, which comprises oxidizing the hydroquinone derivative represented by III) or a salt thereof. [Chemical 12] (In the formula, R 1 is a hydrogen atom, a methyl group or a methoxy group, R 2 and R 3 are the same or different and are a hydrogen atom or a methyl group, R ′ is a lower alkyl group, and R 4 is a hydrogen atom or a lower alkyl group. Group, X means a hydrogen atom, a lower alkyl group, a lower alkoxy group or a halogen atom).
2,6−ジメチル−p−ヒドロキノンとを酸の存在下に
縮合し、得られた3,5−ジメチル−2−(ヒドロキシ
−3−ピリジルメチル)ベンゼン−1,4−ジオールを
酸化することを特徴とする3,5−ジメチル−2−(ヒ
ドロキシ−3−ピリジルメチル)−1,4−ベンゾキノ
ンまたはその塩の製造方法。10. 3,5-Dimethyl-2- (hydroxy-3-pyridylmethyl) benzene obtained by condensing 3-pyridinecarboxaldehyde and 2,6-dimethyl-p-hydroquinone in the presence of an acid. A method for producing 3,5-dimethyl-2- (hydroxy-3-pyridylmethyl) -1,4-benzoquinone or a salt thereof, which comprises oxidizing -1,4-diol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17799794A JP3822257B2 (en) | 1993-07-30 | 1994-07-29 | Process for producing novel hydroquinone and benzoquinone derivatives |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20680993 | 1993-07-30 | ||
| JP23719393 | 1993-08-31 | ||
| JP6-165482 | 1994-07-18 | ||
| JP16548294 | 1994-07-18 | ||
| JP5-237193 | 1994-07-18 | ||
| JP5-206809 | 1994-07-18 | ||
| JP17799794A JP3822257B2 (en) | 1993-07-30 | 1994-07-29 | Process for producing novel hydroquinone and benzoquinone derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0892214A true JPH0892214A (en) | 1996-04-09 |
| JP3822257B2 JP3822257B2 (en) | 2006-09-13 |
Family
ID=27474007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP17799794A Expired - Lifetime JP3822257B2 (en) | 1993-07-30 | 1994-07-29 | Process for producing novel hydroquinone and benzoquinone derivatives |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3822257B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002356474A (en) * | 2000-07-05 | 2002-12-13 | Ishihara Sangyo Kaisha Ltd | Benzoylpyridine derivatives or salts thereof, fungicides containing them as active ingredients, methods for producing them, and intermediates for producing them |
-
1994
- 1994-07-29 JP JP17799794A patent/JP3822257B2/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002356474A (en) * | 2000-07-05 | 2002-12-13 | Ishihara Sangyo Kaisha Ltd | Benzoylpyridine derivatives or salts thereof, fungicides containing them as active ingredients, methods for producing them, and intermediates for producing them |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3822257B2 (en) | 2006-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6388091B1 (en) | Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-{(2-methyl-1H-imidazol-1-yl)methyl}-4H-carbazol-4-one | |
| US5637716A (en) | Processes for the preparation of hydroquinone and benzoquinone derivatives | |
| US5294744A (en) | Formylation process for aromatic aldehydes | |
| JPH0892214A (en) | Production of new hydroquinone and benzoquinone derivative | |
| EP0704435B1 (en) | Process for producing hydroquinone and benzoquinone derivative | |
| JP2826646B2 (en) | 3-substituted-5-halogenopyridine derivatives | |
| JP2001261653A5 (en) | ||
| EP1371638B1 (en) | Pyridazinone derivatives as intermediates of herbicides | |
| JP2726653B2 (en) | Diaminopyrimidine derivative | |
| HU208320B (en) | Process for producing 0-carboxypyridyl and 0-carboxyquinolyl imidazolinones | |
| JP3448635B2 (en) | Sulfenamide compound and method for producing the same | |
| JP3259191B2 (en) | Synthesis of 2,2'-anhydroarabinosyl thymine derivatives | |
| EP0236754B1 (en) | Novel process for preparing 4-acetyl isoquinolinone compounds | |
| JP3338872B2 (en) | Method for producing 1,2-benzisothiazolinone compound | |
| KR100856133B1 (en) | Improved process for preparing atorvastatin | |
| JP3454435B2 (en) | Method for producing 4-aminopyridine derivative | |
| JP2849325B2 (en) | Method for synthesizing 4-halo-5- (hydroxymethyl) imidazole compound | |
| US5164511A (en) | Thioimideazoles useful as intermediates for preparing thiazine | |
| JPS6372684A (en) | Manufacture of piroxicam and synthetic intermediate | |
| JP4449211B2 (en) | 6- (1-fluoroethyl) -5-iodo-4-pyrimidone and process for producing the same | |
| JP3538630B2 (en) | Method for producing quinoline compound | |
| KR100730766B1 (en) | New production method of biphenylacetic acid | |
| JPH09509185A (en) | Process for producing 6-aryloxymethyl-1-hydroxy-4-methyl-2-pyridone | |
| GB2279346A (en) | Benzofuran intermediates | |
| JP2000229920A (en) | Production of amide derivative |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050330 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050330 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051115 |
|
| A521 | Written amendment |
Effective date: 20051118 Free format text: JAPANESE INTERMEDIATE CODE: A523 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Effective date: 20060619 Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Effective date: 20060622 Free format text: JAPANESE INTERMEDIATE CODE: A61 |
|
| R150 | Certificate of patent (=grant) or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090630 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100630 Year of fee payment: 4 |